Our name=our mission. Dedicated to improving patients’ lives using precision oncology to develop novel therapies aimed at key tumor dependencies. (Nasdaq: ORIC)oricpharma.com South San Francisco, CAJoined July 2016
$ORIC President & CEO, @JacobChackoMD and CFO @Dom_Piscitelli will be available for investor one-on-one meetings at the BTIG Virtual Biotechnology Conference on July 29, 2026.
If you're participating, we welcome the opportunity to connect.
Happy Fourth of July!
As we commemorate America's 250th anniversary, we celebrate the innovation and determination that drive progress.
Wishing our employees, collaborators, patients, and communities a safe and happy Independence Day.
Making a difference extends beyond the lab. Our team recently volunteered with Ronald McDonald House and a local food bank, supporting families and helping address food insecurity in our community. We're proud to give back and help strengthen the communities we serve. #GivingBack
This #Juneteenth, we honor the resilience, history, and contributions of Black Americans whose impact has helped shape communities, culture, science, and innovation.
We recognize the importance of diversity in driving innovation and progress.
#DiversityInSTEM
This #PrideMonth, we celebrate the LGBTQIA+ community and the importance of fostering an inclusive environment where everyone feels welcome, engages in healthy debate, & treats each other with respect.
Inclusive teams help create stronger science & better outcomes for patients.
$ORIC CFO @Dom_Piscitelli & CBO @mattpanuwat will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026, at 8:00 a.m. ET.
Listen to the discussion to learn the latest company updates here: bit.ly/3VxP4tj
This #NationalCancerSurvivorsDay, we honor the strength and resilience of cancer survivors everywhere.
At ORIC®, we’re advancing therapies designed to overcome resistance in cancer and expand what’s possible for patients.
$ORIC President & CEO, @JacobChackoMD and CFO @Dom_Piscitelli will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026, at 11:40 a.m. ET.
Listen to the live or archived discussion here: bit.ly/3VxP4tj
This #AANHPIHeritageMonth, we celebrate “Power in Unity: Strengthening Communities Together” and the profound contributions #AANHPI communities have made to science and medicine.
Diverse perspectives drive stronger innovation and better outcomes for patients.
#PowerInUnity
Q1 2026 marked continued momentum for ORIC, highlighted by rinzimetostat data supporting a potential best-in-disease profile and the selection of the RP3D for our first Phase 3 trial in mCRPC, Himalayas-1.
Explore our latest progress and what’s next here:bit.ly/42izTKi
ORIC® VP, Head of Biology Melissa Junttila, Ph.D., & Dir., Head of Bioinformatics Alex Pankov, Ph.D., will present posters at #AACR2026 highlighting preclinical data demonstrating rinzimetostat’s potential as a differentiated treatment for prostate cancer.
Cancer Control Month reminds us that progress takes more than awareness, it takes innovation and action.
We’re working to Overcome Resistance In Cancer by developing therapies designed to address what allows disease to persist.
#CancerControlMonth
Phase 1b data for rinzimetostat + darolutamide in mCRPC highlight potential best-in-disease profile, supporting advancement into Phase 3. Join our webcast at 4:30 p.m. ET today for a detailed review & program update: bit.ly/3VxP4tj
Press release:lnkd.in/gY7wSVtB
We are pleased to share that two preclinical abstracts reinforcing the best-in-class potential of rinzimetostat (ORIC-944) to treat prostate cancer have been accepted for poster presentation at #AACR2026 taking place April 17-22, 2026.
Learn more here: bit.ly/40CeXx6
Happy #EmployeeAppreciationDay to our incredible team!
From team activities to recognition and wellness initiatives, we’re celebrating the people who power our mission to Overcome Resistance In Cancer every day.
Thank you for all you do.
This #InternationalWomensDay, we honor the women powering our mission to Overcome Resistance In Cancer.
Aligned with #GiveToGain, we know that when we invest in women, we strengthen science and outcomes for patients. When women thrive, we all rise.
#WomenInBiotech#IWD2026
2025 was a year of meaningful progress across our clinical pipeline.
We advanced 2 clinical programs with data highlighting differentiated efficacy & safety, building momentum toward potential registrational studies and key milestones ahead.
bit.ly/4aPvOBc
$ORIC CFO @Dom_Piscitelli & CBO @mattpanuwat will participate in a fireside chat at @Oppenheimer’s 36th Annual Healthcare Life Sciences conference on Wed, Feb 25, 2026, at 12:00 p.m. ET.
Listen to the discussion to learn the latest company updates here: bit.ly/3VxP4tj
259 Followers 557 FollowingWe specialize in the Pharmaceutical, Biotech, Genomics, Diagnostics, Medical Device, CDMOs, Life Sciences Construction, AI, MedTech & Digital Healthcare.
693 Followers 1K FollowingHelping R&D Leaders Transform Their Drug Discovery Operations with AI & Automation | Founder @ Aspen Biosciences | Creator of The Ring of Fire Framework
6 Followers 65 FollowingIntroducing Medifirm Intelledge Global — where innovation meets intelligence in healthcare.
Our mission: to empower better health outcomes through smart data
440 Followers 955 FollowingWe help biotech scientists improve the lives of patients by accelerating & scaling drug discovery, cancer research and diagnostic development.
3K Followers 569 FollowingCorrelation Ventures is the AI pioneer in U.S. venture, enabling us to be the most entrepreneur-friendly firm in the industry
2K Followers 1K FollowingAssociate Professor at the Johns Hopkins University School of Medicine studying epigenetic regulation in breast cancer. MSKCC➡️Johns Hopkins
2K Followers 1K FollowingThis account has moved to a new home! Follow us @big4bio for the latest San Francisco Bay Area #LifeScience news, insightful analysis, events, and more.
10K Followers 5K FollowingAdvancing the science and practice of #cancersurgery for the benefit of #cancerpatients #CureCancerTogether @EJSOtweets @myBRESO
2.1M Followers 2K FollowingNature Portfolio’s high-quality products and services across the life, physical, chemical and applied sciences is dedicated to serving the scientific community.
4.7M Followers 458 FollowingCutting-edge research, news, commentary, and visuals from the Science family of journals. Follow @NewsfromScience for stories from our News team.
1K Followers 469 FollowingPresident Emeritus of @BiocomCA Leading advocacy across California and in Washington, DC for our life science industry and for the patients that we serve.
17K Followers 220 FollowingSVP Oncology Global Development @Amgen, Physician-Scientist, Medical Oncologist, immune and molecular target-believer, Tweets my own
16K Followers 703 FollowingEuropean Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life
10.3M Followers 105 FollowingThe first word in business news | Watch Live: https://t.co/nHEpHOAfg3 | Newsletters: https://t.co/nWaCxHTiks | Podcasts: https://t.co/096e9xMJF7
319K Followers 549 FollowingWe’re the world's leading independent cancer charity dedicated to saving lives through research, influence and information.
21K Followers 2K FollowingThe largest multi-professional cancer organisation in Europe; reducing burden and improving quality of care. Organiser of the #EuropeanCancerSummit
113K Followers 2K FollowingThe mission of the American Association for Cancer Research is to prevent and cure cancer through research, education, communication, and collaboration.
151K Followers 2K FollowingAccount of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
996K Followers 158K FollowingOur vision is to end cancer as we know it, for everyone. Learn more at https://t.co/sAXpTAj08D or call us 24/7 at 1-800-227-2345. Proudly a top rated organization.
277K Followers 34K FollowingMedscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.
56K Followers 734 FollowingEarly stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
71K Followers 109 FollowingCapped a 48-year journalism career with a decade-long (and counting) run as founding editor at Endpoints News. Writing a book on cancer care in America: Stage 4
17K Followers 2K FollowingThe leading voice for decision-makers throughout the global biopharma ecosystem. Follow us on LinkedIn for exclusive insights & analysis: https://t.co/V33Z1gfUfZ